Job title: Chief Scientific Officer
Grahame is a biologist with 15 years of experience in academic and industrial drug discovery. After completing his PhD at the MRC LMB, Grahame worked in big pharma for Novartis and then GlaxoWellcome, and then for Lorantis, a start-up biotech. After 7 years working with Ashok Venkitaraman at the MRC Cancer Unit in Cambridge, Grahame co-founded PhoreMost with Torrance and Venkitaraman, and joined the company full-time at Babraham in 2015.
Revealing New RAS Vulnerabilities with Protein Interference (PROTEINi) 2:30 pm
• Oncogenic RAS remains largely undrugged • PROTEINi identifies new targets which are synthetic lethal with RAS • PhoreMost’s SITESEEKER platform provides key pharmacophoric information about how to go about drugging these targetsRead more
day: Day One